Study demonstrates superiority, showing both statistically significant and clinically meaningful reduction in annualized bleeding rate with a generally well-tolerated safety profile compared to ...

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...

Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once monthly injection. The company plans more than 20 anti-obesity trials, ...

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

CHICAGO, Aug 6 (Reuters) - Abraxis BioScience on Monday said it won final approval from U.S. regulators for a generic version of a sodium injection for seizures made by Pfizer Inc. . The U.S. Food and ...

Novo Nordisk has achieved tremendous success in the cardiometabolic treatment space, driven primarily by its semaglutide ...